An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder

NCT00629551 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

825

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: saredutant (SR48968)
DRUG: paroxetine
DRUG: placebo

Sponsor

Sanofi